Acquisition Context Enclara Healthcare was acquired by Humana in December 2019, indicating strategic interest from large payers in hospice pharmacy and PBM services. Sales opportunities may exist within Humana’s care delivery and value-based programs, leveraging Enclara’s hospice pharmacy capabilities.

Growth Gaps With reported revenue below one million dollars and a small employee base, there is potential to scale partnerships by offering scalable tech-enabled care coordination and value-based care solutions that integrate with existing payer and provider ecosystems.

Tech Enablement Current tech stack includes Power Apps, Power Automate, Power BI, QlikView, SAS, Tableau, WordPress, and Imperva. Opportunities exist to upsell advanced analytics, dashboards, and automated workflows to optimize hospice medication management, care coordination, and cost containment.

Market Position As one of the largest hospice pharmacy and PBM providers historically, Enclara sits in a strategic niche with potential for expansion through additional payer contracts, care pathways, and value-based care programs that emphasize patient experience and reduced total cost of care.

Strategic Partnerships Past engagement with Humana signals openness to collaboration with major payers and health systems. Target prospects could include large health plans, Medicare/Medicaid MCOs, and integrated delivery networks seeking specialized hospice pharmacist and PBM services aligned with value-based care.